TRF increased the sensitivity of DDP, while TRF improved the therapeutic effect of DDP, but more importantly reversed the resistance to DDP in NSCLC associated with apoptosis and p53 signaling pathway. Here, TP53 is linked to non-small cell lung carcinoma.